Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 232

1.

Increased expression of IL-24 in chronic spontaneous urticaria.

de Montjoye L, Herman A, Hendrickx E, Chéou P, Blanchetot C, Hofman E, Baeck M, Dumoutier L.

Allergy. 2019 Apr 21. doi: 10.1111/all.13832. [Epub ahead of print] No abstract available.

PMID:
31006117
2.

IL-24 contributes to skin inflammation in Para-Phenylenediamine-induced contact hypersensitivity.

Van Belle AB, Cochez PM, de Heusch M, Pointner L, Opsomer R, Raynaud P, Achouri Y, Hendrickx E, Cheou P, Warnier G, Renauld JC, Baeck M, Dumoutier L.

Sci Rep. 2019 Feb 12;9(1):1852. doi: 10.1038/s41598-018-38156-4.

3.

Endogenous IL-22 is dispensable for experimental glomerulonephritis.

Gnirck AC, Wunderlich M, Becker M, Xiong T, Weinert E, Meyer-Schwesinger C, Dumoutier L, Renauld JC, Huber S, Panzer U, Turner JE.

Am J Physiol Renal Physiol. 2019 Apr 1;316(4):F712-F722. doi: 10.1152/ajprenal.00303.2018. Epub 2019 Feb 6.

PMID:
30724106
4.

Correction: Interleukin-22-deficiency and microbiota contribute to the exacerbation of Toxoplasma gondii-induced intestinal inflammation.

Couturier-Maillard A, Froux N, Piotet-Morin J, Michaudel C, Brault L, Le Bérichel J, Sénéchal A, Robinet P, Chenuet P, Jejou S, Dumoutier L, Renauld JC, Iovanna J, Huber S, Chamaillard M, Quesniaux VFJ, Sokol H, Ryffel B.

Mucosal Immunol. 2019 Jan;12(1):290. doi: 10.1038/s41385-018-0112-6.

PMID:
30504789
5.

IL-9 Integrates the Host-Candida Cross-Talk in Vulvovaginal Candidiasis to Balance Inflammation and Tolerance.

Renga G, Borghi M, Oikonomou V, Mosci P, Bartoli A, Renauld JC, Romani L, Costantini C.

Front Immunol. 2018 Nov 20;9:2702. doi: 10.3389/fimmu.2018.02702. eCollection 2018.

6.

Omalizumab in chronic spontaneous urticaria: A real-life experience of dose and intervals adjustments in Belgium.

de Montjoye L, Herman A, Dumoutier L, Lambert M, Tromme I, Baeck M.

Ann Allergy Asthma Immunol. 2018 Nov;121(5):620-622. doi: 10.1016/j.anai.2018.07.002. Epub 2018 Jul 6. No abstract available.

PMID:
30392532
7.

Increased expression of interleukin-9 in patients with allergic contact dermatitis caused by p-phenylenediamine.

Baeck M, Herman A, de Montjoye L, Hendrickx E, Chéou P, Cochez PM, Dumoutier L.

Contact Dermatitis. 2018 Dec;79(6):346-355. doi: 10.1111/cod.13123. Epub 2018 Sep 28.

PMID:
30264909
8.

The TLR7 ligand R848 prevents mouse graft-versus-host disease and cooperates with anti-interleukin-27 antibody for maximal protection and regulatory T-cell upregulation.

Gaignage M, Marillier RG, Cochez PM, Dumoutier L, Uyttenhove C, Coutelier JP, Van Snick J.

Haematologica. 2019 Feb;104(2):392-402. doi: 10.3324/haematol.2018.195628. Epub 2018 Sep 13.

9.

IL-9 receptor signaling in memory B cells regulates humoral recall responses.

Takatsuka S, Yamada H, Haniuda K, Saruwatari H, Ichihashi M, Renauld JC, Kitamura D.

Nat Immunol. 2018 Sep;19(9):1025-1034. doi: 10.1038/s41590-018-0177-0. Epub 2018 Aug 6.

PMID:
30082831
10.

IL-9 and Mast Cells Are Key Players of Candida albicans Commensalism and Pathogenesis in the Gut.

Renga G, Moretti S, Oikonomou V, Borghi M, Zelante T, Paolicelli G, Costantini C, De Zuani M, Villella VR, Raia V, Del Sordo R, Bartoli A, Baldoni M, Renauld JC, Sidoni A, Garaci E, Maiuri L, Pucillo C, Romani L.

Cell Rep. 2018 May 8;23(6):1767-1778. doi: 10.1016/j.celrep.2018.04.034.

11.

Interleukin-22-deficiency and microbiota contribute to the exacerbation of Toxoplasma gondii-induced intestinal inflammation.

Couturier-Maillard A, Froux N, Piotet-Morin J, Michaudel C, Brault L, Le Bérichel J, Sénéchal A, Robinet P, Chenuet P, Jejou S, Dumoutier L, Renauld JC, Iovanna J, Huber S, Chamaillard M, Quesniaux V, Sokol H, Chamaillard M, Ryffel B.

Mucosal Immunol. 2018 Jul;11(4):1181-1190. doi: 10.1038/s41385-018-0005-8. Epub 2018 May 4. Erratum in: Mucosal Immunol. 2019 Jan;12(1):290.

PMID:
29728643
12.

Interleukin-22 level is negatively correlated with neutrophil recruitment in the lungs in a Pseudomonas aeruginosa pneumonia model.

Broquet A, Jacqueline C, Davieau M, Besbes A, Roquilly A, Martin J, Caillon J, Dumoutier L, Renauld JC, Heslan M, Josien R, Asehnoune K.

Sci Rep. 2017 Sep 8;7(1):11010. doi: 10.1038/s41598-017-11518-0.

13.

IL-22 induces Reg3γ and inhibits allergic inflammation in house dust mite-induced asthma models.

Ito T, Hirose K, Saku A, Kono K, Takatori H, Tamachi T, Goto Y, Renauld JC, Kiyono H, Nakajima H.

J Exp Med. 2017 Oct 2;214(10):3037-3050. doi: 10.1084/jem.20162108. Epub 2017 Aug 15.

14.

Can serum cytokine profile discriminate irritant-induced and allergen-induced symptoms? A cross-sectional study in workers mostly exposed to laboratory animals.

Lemaire M, Oppliger A, Hotz P, Renauld JC, Braun J, Maggi M, Barresi F, Schmid-Grendelmeier P, Huaux F, Dressel H.

Occup Environ Med. 2017 Aug;74(8):592-600. doi: 10.1136/oemed-2016-104137. Epub 2017 Apr 17.

PMID:
28416643
15.

Limited Presence of IL-22 Binding Protein, a Natural IL-22 Inhibitor, Strengthens Psoriatic Skin Inflammation.

Martin JC, Wolk K, Bériou G, Abidi A, Witte-Händel E, Louvet C, Kokolakis G, Drujont L, Dumoutier L, Renauld JC, Sabat R, Josien R.

J Immunol. 2017 May 1;198(9):3671-3678. doi: 10.4049/jimmunol.1700021. Epub 2017 Mar 29.

16.

Ccr6 Is Dispensable for the Development of Skin Lesions Induced by Imiquimod despite its Effect on Epidermal Homing of IL-22-Producing Cells.

Cochez PM, Michiels C, Hendrickx E, Dauguet N, Warnier G, Renauld JC, Dumoutier L.

J Invest Dermatol. 2017 May;137(5):1094-1103. doi: 10.1016/j.jid.2016.12.023. Epub 2017 Jan 20.

17.

A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosis.

Moretti S, Renga G, Oikonomou V, Galosi C, Pariano M, Iannitti RG, Borghi M, Puccetti M, De Zuani M, Pucillo CE, Paolicelli G, Zelante T, Renauld JC, Bereshchenko O, Sportoletti P, Lucidi V, Russo MC, Colombo C, Fiscarelli E, Lass-Flörl C, Majo F, Ricciotti G, Ellemunter H, Ratclif L, Talesa VN, Napolioni V, Romani L.

Nat Commun. 2017 Jan 16;8:14017. doi: 10.1038/ncomms14017.

18.

Flagellin-Mediated Protection against Intestinal Yersinia pseudotuberculosis Infection Does Not Require Interleukin-22.

Porte R, Van Maele L, Muñoz-Wolf N, Foligné B, Dumoutier L, Tabareau J, Cayet D, Gosset P, Jonckheere N, Van Seuningen I, Chabalgoity JA, Simonet M, Lamkanfi M, Renauld JC, Sirard JC, Carnoy C.

Infect Immun. 2017 Jan 26;85(2). pii: e00806-16. doi: 10.1128/IAI.00806-16. Print 2017 Feb.

19.

Corrigendum: Distinct Transcriptomic Features Are Associated with Transitional and Mature B-Cell Populations in the Mouse Spleen.

Kleiman E, Salyakina D, De Heusch M, Hoek KL, Llanes JM, Castro I, Wright JA, Clark ES, Dykxhoorn DM, Capobianco E, Takeda A, McCormack RM, Podack ER, Renauld JC, Khan WN.

Front Immunol. 2016 Jul 4;7:267. doi: 10.3389/fimmu.2016.00267. eCollection 2016.

20.

Loss of mutL homolog-1 (MLH1) expression promotes acquisition of oncogenic and inhibitor-resistant point mutations in tyrosine kinases.

Springuel L, Losdyck E, Saussoy P, Turcq B, Mahon FX, Knoops L, Renauld JC.

Cell Mol Life Sci. 2016 Dec;73(24):4739-4748. Epub 2016 Jul 19.

PMID:
27436342

Supplemental Content

Loading ...
Support Center